Vimarsana
Biggest News Aggregation in the World

Page 40 - Ryan Taylor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ryan Taylor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ryan Taylor Today - Breaking & Trending Today

Palantir projects revenue above estimates on demand for AI platform - Vimarsana News

Palantir projects revenue above estimates on demand for AI platform

Data analytics firm Palantir Technologies forecast fourth-quarter revenue above market estimates on Thursday, betting on strong demand for its new artificial intelligence platform from clients...

Palantir Technologies (PLTR) Q3 2023 Earnings Call Transcript - Vimarsana News

Palantir Technologies (PLTR) Q3 2023 Earnings Call Transcript

PLTR earnings call for the period ending September 30, 2023.

Source: fool.com
Palantir surges as AI to power growth after 'most significant' profit - Vimarsana News

Palantir surges as AI to power growth after 'most significant' profit

:Palantir signaled on Thursday its artificial intelligence offerings would aid growth in the last three months of 2023, after delivering a fourth straight quarterly profit on growing demand for its data analytics services from corporates.The company's shares surged nearly 20 per cent and CEO Alex Karp said th

Palantir surges as AI to power growth after 'most significant' profit - Vimarsana News

Palantir surges as AI to power growth after 'most significant' profit

(Reuters) -Palantir signaled on Thursday its artificial intelligence offerings would aid growth in the last three months of 2023, after delivering a fourth straight quarterly profit on growing demand for its data analytics services from corporates. The company's shares surged nearly 20% and CEO Alex Karp said the profit was the "most significant" in its 20-year history and it was now eligible for inclusion in the S&P 500. Palantir expects revenue to be between $599 million and $603 million in the fourth quarter, the midpoint of which was above analysts' estimates of ...

Source: yahoo.com
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gastroenterology (ACG) Annual Scientific Meeting - Vimarsana News

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gastroenterology (ACG) Annual Scientific Meeting

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced that three posters detailing findings from...